Status:

COMPLETED

Micra Atrial TRacking Using A Ventricular AccELerometer 2

Lead Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Conditions:

Atrioventricular Conduction Block

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of the Micra Atrial TRacking Using A Ventricular AccELerometer 2 (MARVEL 2) study is to demonstrate safe and effective operation of the MARVEL 2 features for providing AV synchronous pacin...

Detailed Description

The MARVEL 2 study is an acute, prospective, global, multi-center, software-download clinical study. The study is planned to be conducted in US, Europe, and Asia. The study is expected to be conducted...

Eligibility Criteria

Inclusion

  • Subject has been implanted with a Micra TPS (Model MC1VR01) with remaining device longevity of 6 years or more or is expected to be implanted with a Micra TPS.
  • Subject has history of AV block\*
  • Subject is ≥ 18 years old and as per required local law.
  • Subject (and/or witness as applicable per local regulations) provides signed and dated authorization and/or consent per institution and local requirements.
  • Subject is willing and able to comply with the protocol. \*This includes subjects with normal sinus function and persistent 3rd degree AV block and subjects with other forms of AV block.

Exclusion

  • Subject is currently enrolled or planning to participate in a potentially confounding drug or device trial during the study. Co-enrollment in concurrent trials is only allowed when documented pre-approval is obtained from the Medtronic Clinical Research Specialist.
  • Subject is pregnant (if required by local law, women of child-bearing potential must undergo a pregnancy test within seven days prior to MARVEL 2 study procedures).
  • Subject meets any exclusion criteria required by local law (age or other).

Key Trial Info

Start Date :

January 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 7 2019

Estimated Enrollment :

77 Patients enrolled

Trial Details

Trial ID

NCT03752151

Start Date

January 22 2019

End Date

August 7 2019

Last Update

June 4 2020

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Baptist Medical Center Jacksonville

Jacksonville, Florida, United States, 32207

2

Baptist Hospital

Miami, Florida, United States, 33176

3

North Shore University Hospital- Northwell

Manhasset, New York, United States, 11030

4

NYU Langone Medical Center

New York, New York, United States, 10016